Clariant AG
SIX:CLN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.87
15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Clariant AG
Capital Expenditures
Clariant AG
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Clariant AG
SIX:CLN
|
Capital Expenditures
-CHf205m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Capital Expenditures
-CHf279.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Givaudan SA
SIX:GIVN
|
Capital Expenditures
-CHf277m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Capital Expenditures
-CHf29.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Capital Expenditures
-CHf162.9m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-36%
|
|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Capital Expenditures
-€684m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clariant AG
Glance View
In the shadow of the Swiss Alps, Clariant AG has carved out its niche as a formidable player in the specialty chemicals landscape. Emerging from the restructuring endeavors of Sandoz in the mid-1990s, Clariant embarked on a journey of metamorphosis, morphing from a collection of diverse chemical assets into a global leader in specialty chemicals. Known for its strategic focus on innovation and sustainability, Clariant divides its operations into critical business areas: Care Chemicals, Catalysis, and Natural Resources. Whether creating advanced emulsifiers for personal care products, catalysts that drive higher yields for petrochemicals, or additives that enhance oil recovery, Clariant continuously adapts to market demands through a commitment to research and development, placing a premium on delivering high-performance and sustainable solutions across industries. Clariant’s business model is deeply tied to innovation-driven solutions that cater to the evolving needs of its clients. The company invests significantly in R&D, with laboratories and research centers spread across strategic global locations, fostering a culture of innovation that synergizes with local markets. Through its intelligent use of its portfolio, Clariant generates revenue by not only meeting the basic needs of its customers but by shaping their expectations toward value-added, environmentally friendly products. This has garnered them a reputation for leadership in sustainability, evidenced by their initiatives aimed at reducing their environmental footprint and facilitating the transition to a low-carbon economy. By focusing on these strategic pillars, Clariant continues to secure its financial position, creating shareholder value while contributing positively to society at large.
See Also
What is Clariant AG's Capital Expenditures?
Capital Expenditures
-205m
CHF
Based on the financial report for Jun 30, 2024, Clariant AG's Capital Expenditures amounts to -205m CHF.
What is Clariant AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
10%
Over the last year, the Capital Expenditures growth was -4%. The average annual Capital Expenditures growth rates for Clariant AG have been 15% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
